Skip to Main Content

Clinical Psychopharmacology Institute Faculty

The APNA Clinical Psychopharmacology Institute Program Committee has curated a lineup of nationally recognized speakers in psychiatric-mental health nursing, neuroscience, and psychopharmacology for the 2026 program.

This prestigious faculty brings together cutting-edge clinical insight, scientific depth, and holistic nurse perspective.

 

Full program coming soon, and registration will open early next year!

2026 CPI Faculty Selected by Nurses for Nurses

Compton headshot
Wilson Compton, MD, MPE

Deputy Director
National Institute on Drug Abuse (NIDA) of the National Institutes of Health

Keynote Speaker

Cpi 2025 Square
Anyi Atabong, DNP, PMHNP-BC, FNP-C, PMH-C

CEO & Co-Founder, Capital Multi Health Group

Timing, Treatment, Trust: Shaping the Trajectory of Bipolar Disorder

Cpi 2025 Square
Lee Cohen, MD

Director, The Ammon-Pinizzotto Center for Women’s Mental Health; Associate Chief of Psychiatry for Philanthropy and Department Communications, Massachusetts General Hospital

Women’s mental health

Cpi 2025 Square
Oliver Freudenreich, MD, FACLP

Professor of Clinical Psychiatry, Harvard Medical School; Co-Director, MGH Psychosis Clinical and Research Program
Massachusetts General Hospital

Treatment as Prevention: Stage-Based Schizophrenia Care

Lyons Hardy
Lyons Hardy, MSN, PMHNP

Associate Professor, Virginia Commonwealth University

Dementia types and psychopharmacology

Addictions LeahyLaura
Laura Leahy DrNP, APRN, FAANP, FAANB

Board Certified Psychiatric & Addictions Advanced Practice Nurse; Founder, APNSolutions, LLC

Revisiting older medications

jeremy-mills
Jeremy Mills, DNP, APRN, PMHNP-BC

Clinical Assistant Professor, Coordinator, Psychiatric-Mental Health Nurse Practitioner Program, University of Tennessee

Treatment for nicotine cessation, including vaping

Cpi 2025 Square
Anthony L. Rostain, MD, MA

Chair, Department of Psychiatry & Behavioral Health, Cooper University Health Care; Professor of Psychiatry & Pediatrics, Cooper Medical School of Rowan University

ADHD & neurodevelopmental disorders across the lifespan

Cpi 2025 Square
Natalie Taylor, PMHNP-BC

Medical Director, Wild Oaks & Richmond Creative Counseling

Eating Disorders

Cpi 2025 Square
Tony Thrasher, DO, MBA, CPE, DFAPA

Medical Director of Crisis Services, Milwaukee County Behavioral Health Division

Emergency room psychiatry

Cpi 2025 Square
Jared Vega, JD, FNP, Psych NP

Psychiatric-Mental Health Nurse Practitioner

Prescribing with Protection: Legal Implications and Documentation for PMHNPs in Psychopharmacology

Kirby Williams
Kirby Williams, MSN, PMHNP-BC

Founder, The PMHNP Source & Beacon Behavioral Health and Consulting; Co-founder, The Society of PMHNPs of Color

Drug-Induced Movement Disorders: From Recognition to Real-World Management

Your dynamic community of Psychiatric-Mental Health Nurses.

Connect with fellow psychiatric-mental health nurses, be the first to know about evidence-based resources and programs, and participate in exclusive opportunities to advance the care and treatment of those with mental health & substance use needs.

JOIN TODAY MEMBER COMMUNITY

Footer Cta